Sign In

Login

Password

Forgot Password ? Sign Up

5-HT7 receptor (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "5-HT7 receptor" in Serbian language version.

refsWebsite
Global rank Serbian rank
24nih.gov
4th place
8th place
21doi.org
2nd place
4th place
1gpcr.org
low place
low place
1archive.org
6th place
5th place

archive.org

doi.org

gpcr.org

nih.gov

ncbi.nlm.nih.gov

  • „Snake-like view of 5ht7r_human”. GPCRDB: Information system for G protein-coupled receptors. www.gpcr.org.  This diagram was created with the Residue-based Diagram generator (RbDg) (Konvicka K, Campagne F, Weinstein H (2000). „Interactive construction of residue-based diagrams of proteins: the RbDe web service”. Protein Eng. 13 (6): 395—6. PMID 10877849. ; Skrabanek L, Campagne F, Weinstein H (2003). „Building protein diagrams on the web with the residue-based diagram editor RbDe”. Nucleic Acids Res. 31 (13): 3856—8. PMC 168959 Слободан приступ. PMID 12824436. )
  • Vanhoenacker P, Haegeman G, Leysen JE (2000). „5-HT7 receptors: current knowledge and future prospects”. Trends Pharmacol. Sci. 21 (2): 70—7. PMID 10664612. doi:10.1016/S0165-6147(99)01432-7. 
  • Ruat M, Traiffort E, Leurs R, Tardivel-Lacombe J, Diaz J, Arrang JM, Schwartz JC (1993). „Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation”. Proc. Natl. Acad. Sci. U.S.A. 90 (18): 8547—51. PMC 47394 Слободан приступ. PMID 8397408. doi:10.1073/pnas.90.18.8547. 
  • Bard JA, Zgombick J, Adham N, Vaysse P, Branchek TA, Weinshank RL (1993). „Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase”. J. Biol. Chem. 268 (31): 23422—6. PMID 8226867. 
  • Mnie-Filali O, Lambás-Señas L, Zimmer L, Haddjeri N (2007). „5-HT7 receptor antagonists as a new class of antidepressants”. Drug News Perspect. 20 (10): 613—8. PMID 18301795. doi:10.1358/dnp.2007.20.10.1181354. 
  • Heidmann DE, Metcalf MA, Kohen R, Hamblin MW (1997). „Four 5-hydroxytryptamine7 (5-HT7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron-exon organization”. J. Neurochem. 68 (4): 1372—81. PMID 9084407. doi:10.1046/j.1471-4159.1997.68041372.x. 
  • Hedlund PB, Sutcliffe JG (2004). „Functional, molecular and pharmacological advances in 5-HT7 receptor research”. Trends Pharmacol. Sci. 25 (9): 481—6. PMID 15559250. doi:10.1016/j.tips.2004.07.002. 
  • Sprouse J, Reynolds L, Li X, Braselton J, Schmidt A (2004). „8-OH-DPAT as a 5-HT7 agonist: phase shifts of the circadian biological clock through increases in cAMP production”. Neuropharmacology. 46 (1): 52—62. PMID 14654097. doi:10.1016/j.neuropharm.2003.08.007. 
  • Powell SL, Gödecke T, Nikolic D, Chen SN, Ahn S, Dietz B, Farnsworth NR, van Breemen RB, Lankin DC, Pauli GF, Bolton JL (2008). „In vitro serotonergic activity of black cohosh and identification of N(omega)-methylserotonin as a potential active constituent”. J Agric Food Chem. 56 (24): 1718—1726. PMID 19049296. doi:10.1021/jf803298z. 
  • Leopoldo M, Lacivita E, Contino M, Colabufo NA, Berardi F, Perrone R (2007). „Structure-activity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a class of 5-HT7 receptor agents. 2”. J. Med. Chem. 50 (17): 4214—21. PMID 17649988. doi:10.1021/jm070487n. 
  • Leopoldo, M.; Berardi, F.; Colabufo, NA; et al. (2004). „Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents”. J. Med. Chem. 47 (26): 6616—24. PMID 15588097. doi:10.1021/jm049702f. 
  • Pittalà V, Salerno L, Modica M, Siracusa MA, Romeo G (2007). „5-HT7 receptor ligands: recent developments and potential therapeutic applications”. Mini Rev Med Chem. 7 (9): 945—60. PMID 17897083. doi:10.2174/138955707781662663. 
  • Leopoldo, M. (2004). „Serotonin(7) receptors (5-HT(7)Rs) and their ligands”. Curr. Med. Chem. 11 (5): 629—61. PMID 15032609. doi:10.2174/0929867043455828. 
  • Krobert KA and Levy FO (2002). „The human 5-HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects”. Br J Pharmacol. 135 (6): 1563—1571. . (2002). „The human 5-HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects.”. British journal of pharmacology. 135 (6): 1563—71. PMC 1573253 Слободан приступ. PMID 11906971. doi:10.1038/sj.bjp.0704588. 
  • Volk, B.; Barkóczy, J.; Hegedus, E.; et al. (2008). „(Phenylpiperazinyl-butyl)oxindoles as selective 5-HT7 receptor antagonists”. J. Med. Chem. 51 (8): 2522—32. PMID 18361484. doi:10.1021/jm070279v. 
  • Abbas AI, Hedlund PB, Huang XP, Tran TB, Meltzer HY, Roth BL (2009). „Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo”. Psychopharmacology (Berl.). 205 (1): 119—28. PMC 2821721 Слободан приступ. PMID 19337725. doi:10.1007/s00213-009-1521-8. 
  • Romero G, Pujol M, Pauwels PJ (2006). „Reanalysis of constitutively active rat and human 5-HT7(a) receptors in HEK-293F cells demonstrates lack of silent properties for reported neutral antagonists”. Naunyn Schmiedebergs Arch. Pharmacol. 374 (1): 31—9. PMID 16967291. doi:10.1007/s00210-006-0093-y. 
  • Forbes, IT; Dabbs, S.; Duckworth, DM; et al. (1998). „(R)-3,N-dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl) propyl]benzenesulfonamide: the first selective 5-HT7 receptor antagonist”. J. Med. Chem. 41 (5): 655—7. PMID 9513592. doi:10.1021/jm970519e. 
  • Mahé C, Loetscher E, Feuerbach D, Müller W, Seiler MP, Schoeffter P (2004). „Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors”. Eur. J. Pharmacol. 495 (2-3): 97—102. PMID 15249157. doi:10.1016/j.ejphar.2004.05.033. 
  • Lovell PJ, Bromidge SM, Dabbs S, Duckworth DM, Forbes IT, Jennings AJ, King FD, Middlemiss DN, Rahman SK, Saunders DV, Collin LL, Hagan JJ, Riley GJ and Thomas DR (2000) A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970). J Med Chem (2000). „A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970).”. Journal of medicinal chemistry. 43 (3): 342—5. PMID 10669560. doi:10.1021/jm991151j. 
  • Forbes, IT; Douglas, S.; Gribble, AD; et al. (2002). „SB-656104-A: a novel 5-HT(7) receptor antagonist with improved in vivo properties”. Bioorg. Med. Chem. Lett. 12 (22): 3341—4. PMID 12392747. doi:10.1016/S0960-894X(02)00690-X. 
  • Zhang J, Ferguson SS, Barak LS, Aber MJ, Giros B, Lefkowitz RJ and Caron MG (1997) Molecular mechanisms of G protein-coupled receptor signaling: role of G protein-coupled receptor kinases and arrestins in receptor desensitization and resensitization. Receptors Channels 5(3-4):193-199. (1997). „Molecular mechanisms of G protein-coupled receptor signaling: role of G protein-coupled receptor kinases and arrestins in receptor desensitization and resensitization.”. Receptors & channels. 5 (3-4): 193—9. PMID 9606723. 
  • Smith C, Rahman T, Toohey N, Mazurkiewicz J, Herrick-Davis K and Teitler M (2006) Risperidone irreversibly binds to and inactivates the h5-HT7 serotonin receptor. Mol Pharmacol (2006). „Risperidone irreversibly binds to and inactivates the h5-HT7 serotonin receptor.”. Molecular pharmacology. 70 (4): 1264—70. PMID 16870886. doi:10.1124/mol.106.024612. 
  • Knight JA, Smith C, Toohey N, Klein MT and Teitler M (2009) Pharmacological analysis of the novel, rapid, and potent inactivation of the human 5-Hydroxytryptamine7 receptor by risperidone, 9-OH-Risperidone, and other inactivating antagonists. Mol Pharmacol (2009). „Pharmacological analysis of the novel, rapid, and potent inactivation of the human 5-Hydroxytryptamine7 receptor by risperidone, 9-OH-Risperidone, and other inactivating antagonists.”. Molecular pharmacology. 75 (2): 374—80. PMC 2671286 Слободан приступ. PMID 18996971. doi:10.1124/mol.108.052084.